Trials / Recruiting
RecruitingNCT05459597
Antiepileptic Drugs in Elderly Patients
Population Pharmacokinetics, Effectiveness and Safety of Antiepileptic Drugs in Elderly Patients
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Wei Zhao · Academic / Other
- Sex
- All
- Age
- 65 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The purpose is to study the population pharmacokinetics, effectiveness and safety of antiepileptic drug (phenytoin, carbamazepine, lamotrigine, levetiracetam, parempanel, etc) in elderly patients and recommend optimized dosage regimens.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | antiepileptic drugs | phenytoin, carbamazepine, lamotrigine, levetiracetam, perampanel, etc. as part of routine treatment. |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2028-03-30
- Completion
- 2028-06-30
- First posted
- 2022-07-15
- Last updated
- 2022-07-15
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05459597. Inclusion in this directory is not an endorsement.